Pages that link to "Q43920218"
Jump to navigation
Jump to search
The following pages link to Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis (Q43920218):
Displaying 50 items.
- Topical tacrolimus for atopic dermatitis (Q24186624) (← links)
- Dry eye: an inflammatory ocular disease (Q26852044) (← links)
- Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials (Q31149849) (← links)
- A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis (Q33896413) (← links)
- Eczema. (Q33910639) (← links)
- Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis (Q34882570) (← links)
- International Consensus Conference on Atopic Dermatitis II (ICCAD II*): clinical update and current treatment strategies (Q35106685) (← links)
- Tacrolimus ointment for the management of atopic dermatitis (Q35121501) (← links)
- Complementary therapy for atopic eczema and other allergic skin diseases (Q35199979) (← links)
- Diagnosis and treatment of chronic actinic dermatitis (Q35200016) (← links)
- Long-term safety of tacrolimus ointment in children treated for atopic dermatitis (Q35208400) (← links)
- Tacrolimus treatment of atopic eczema/dermatitis syndrome (Q35539345) (← links)
- Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. (Q35809490) (← links)
- Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. (Q35815978) (← links)
- Macrolactam immunomodulators (tacrolimus and pimecrolimus): new horizons in the topical treatment of inflammatory skin diseases (Q35922000) (← links)
- A Randomized, Open-Label, Multicenter Trial of Topical Tacrolimus for the Treatment of Pruritis in Patients with Atopic Dermatitis (Q38632254) (← links)
- The role of topical calcineurin inhibitors in atopic dermatitis (Q35952647) (← links)
- Pimecrolimus -- an anti-inflammatory drug targeting the skin (Q35961095) (← links)
- Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions (Q36093284) (← links)
- The economics of topical immunomodulators for the treatment of atopic dermatitis. (Q36165229) (← links)
- Platycodon grandiflorus alleviates DNCB-induced atopy-like dermatitis in NC/Nga mice (Q36313468) (← links)
- Problem-based learning: a review of current issues relevant to physiotherapy education. (Q36356956) (← links)
- Recent developments in the treatment of adult atopic dermatitis (Q36486329) (← links)
- Topical tacrolimus in the management of atopic dermatitis in Japan (Q36466798) (← links)
- Atopic eczema: what's new? (Q36473293) (← links)
- Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan (Q36680989) (← links)
- A systematic review of the safety of topical therapies for atopic dermatitis. (Q36708358) (← links)
- A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis. (Q36784236) (← links)
- The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review (Q36940038) (← links)
- Management of itch in atopic dermatitis (Q36991444) (← links)
- The role of pimecrolimus cream 1% (Elidel)) in managing adult atopic eczema (Q37049986) (← links)
- New and emerging trends in the treatment of atopic dermatitis. (Q37634335) (← links)
- Evolution of Conventional Therapy in Atopic Dermatitis (Q37776585) (← links)
- Update on the management of chronic eczema: new approaches and emerging treatment options (Q37857682) (← links)
- Health Outcomes in Atopic Dermatitis (Q37961015) (← links)
- Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis (Q37977478) (← links)
- Long term treatment concepts and proactive therapy for atopic eczema (Q38033549) (← links)
- Atopic dermatitis - all you can do from the outside (Q38203595) (← links)
- An update on current pharmacotherapy options in atopic dermatitis (Q38210447) (← links)
- Advances in the diagnosis and therapeutic management of atopic dermatitis. (Q38211352) (← links)
- Difficult to control atopic dermatitis (Q40473325) (← links)
- Erythema Dyschromicum Perstans: Response to Topical Tacrolimus (Q41836622) (← links)
- Tacrolimus ointment in the management of atopic dermatitis (Q42081579) (← links)
- Topical tacrolimus as treatment of atopic dermatitis (Q42263734) (← links)
- Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies (Q43200436) (← links)
- Topical tacrolimus treatment of atopic eyelid disease (Q44340427) (← links)
- Topic calcineurin inhibitors (Q44352951) (← links)
- Topical corticosteroids versus topical inhibitors of calcineurin (Q44386076) (← links)
- The treatment of atopic dermatitis in adults with topical calcineurin inhibitors (Q44420864) (← links)
- Practice experience with topical calcineurin inhibitors (Q44420871) (← links)